2025-15177Rule

DEA Hands Dipentylone Its Own VIP Spot on the Naughty Drug List

Published Date: 8/8/2025

Rule

Summary

The DEA is giving dipentylone its own official spot on the list of the most tightly controlled drugs (Schedule I). This means dipentylone is now clearly recognized and tracked separately from similar drugs. People who make, sell, or use this drug will need to follow these updated rules right away, but there’s no new cost involved.

Analyzed Economic Effects

1 provisions identified: 0 benefits, 1 costs, 0 mixed.

Dipentylone Added to Schedule I

The DEA has added 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (dipentylone; N,N-dimethylpentylone) as a separately listed Schedule I controlled substance with its own DEA drug code. Dipentylone is now explicitly listed apart from its positional isomer N-ethylpenthylone (which was controlled on August 31, 2018). People who make, sell, or possess dipentylone must follow the Schedule I rules right away, and the rule says there is no new financial cost involved.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
8/8/2025

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in